SG Americas Securities
OXFD

SG Americas Securities’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

SG Americas Securities’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,717
Closed -$114K – 3552
2016
Q2 		$114K Buy
+12,717
New +$125K ﹤0.01% 2330

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SG Americas Securities's OXFD Position: Q3 2016 in Review

SG Americas Securities sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2016, closing a stake of 12,717 shares — an estimated $114K sold.

SG Americas Securities first reported a position in OXFD in Q2 2016 and held it in 1 quarter. The position peaked at $114K in Q2 2016. 62 funds tracked by Wall St. Rank hold OXFD as of Q3 2016.

  • SG Americas Securities reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • SG Americas Securities sold 12,717 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2016, an estimated $114K.
  • SG Americas Securities first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2016 and held it in 1 quarter.
  • SG Americas Securities's Oxford Immunotec Global PLC Ordinary Shares position peaked at $114K in Q2 2016.
  • 62 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2016.

Based on SG Americas Securities's 13F filing for Q3 2016, filed 8 Nov 2016.